KR20030074610A - Ｐｃｐ 중독 및 ｐｃｐ 중독 관련 행동의 치료방법 - Google Patents

Ｐｃｐ 중독 및 ｐｃｐ 중독 관련 행동의 치료방법 Download PDF

Info

Publication number
KR20030074610A
KR20030074610A KR10-2003-7005616A KR20037005616A KR20030074610A KR 20030074610 A KR20030074610 A KR 20030074610A KR 20037005616 A KR20037005616 A KR 20037005616A KR 20030074610 A KR20030074610 A KR 20030074610A
Authority
KR
South Korea
Prior art keywords
pcp
mammal
gvg
administered
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2003-7005616A
Other languages
English (en)
Korean (ko)
Inventor
듀이스테판엘.
부로디조나단디.
애쉬비찰스알.주니어
Original Assignee
브룩하벤 싸이언스 어쏘씨에이츠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브룩하벤 싸이언스 어쏘씨에이츠 filed Critical 브룩하벤 싸이언스 어쏘씨에이츠
Publication of KR20030074610A publication Critical patent/KR20030074610A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
KR10-2003-7005616A 2000-10-23 2001-03-07 Ｐｃｐ 중독 및 ｐｃｐ 중독 관련 행동의 치료방법 Ceased KR20030074610A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/694,040 2000-10-23
US09/694,040 US6395783B1 (en) 2000-10-23 2000-10-23 Treatment of PCP addiction and PCP addiction-related behavior
PCT/US2001/007233 WO2002034249A1 (en) 2000-10-23 2001-03-07 Treatment of pcp addiction and pcp addiction-related behavior

Publications (1)

Publication Number Publication Date
KR20030074610A true KR20030074610A (ko) 2003-09-19

Family

ID=24787164

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7005616A Ceased KR20030074610A (ko) 2000-10-23 2001-03-07 Ｐｃｐ 중독 및 ｐｃｐ 중독 관련 행동의 치료방법

Country Status (17)

Country Link
US (1) US6395783B1 (https=)
EP (1) EP1335717A4 (https=)
JP (1) JP2004512301A (https=)
KR (1) KR20030074610A (https=)
CN (2) CN1234352C (https=)
AU (2) AU4201101A (https=)
BR (1) BR0114898A (https=)
CA (1) CA2426210C (https=)
CZ (1) CZ20031431A3 (https=)
HR (1) HRP20030322A2 (https=)
HU (1) HUP0301441A3 (https=)
IL (2) IL155574A0 (https=)
MX (1) MXPA03003589A (https=)
NO (1) NO20031814L (https=)
NZ (1) NZ526072A (https=)
PL (1) PL361028A1 (https=)
WO (1) WO2002034249A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN114903006B (zh) * 2021-02-09 2024-08-02 中国科学院脑科学与智能技术卓越创新中心 一种非人灵长类动物物质成瘾模型的构建方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133002B (en) 1982-12-30 1986-01-29 Merrell Toraude & Co Process for preparing 4-amino-5-hexenoic acid
GB8311804D0 (en) 1983-04-29 1983-06-02 Merrell Toraude & Co Treatment of seizure disorders and pharmaceutical compositions
US4595697A (en) 1984-03-28 1986-06-17 Merrell Dow Pharmaceuticals Inc. Treatment of seizure disorders and pharmaceutical compositions useful therein
US5189064A (en) 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
JPH03500411A (ja) 1987-10-07 1991-01-31 マトリックス　テクノロジーズ　インコーポレーテッド コカイン中毒の処置および治療薬
US5102913A (en) * 1991-07-01 1992-04-07 Halikas James A Treatment for cocaine use employing valproic acid
KR20010031470A (ko) 1997-10-28 2001-04-16 둘락 노먼 씨. 포유동물의 갈망을 감소시키는 방법
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
CN100548290C (zh) 1999-02-24 2009-10-14 辛辛那提大学 氨基磺酸酯衍生物用于治疗冲动控制障碍的用途

Also Published As

Publication number Publication date
JP2004512301A (ja) 2004-04-22
WO2002034249A1 (en) 2002-05-02
IL155574A0 (en) 2003-11-23
CN1476326A (zh) 2004-02-18
CZ20031431A3 (cs) 2004-06-16
HUP0301441A3 (en) 2011-07-28
AU2001242011B2 (en) 2005-11-03
BR0114898A (pt) 2003-08-12
NZ526072A (en) 2004-08-27
CN1234352C (zh) 2006-01-04
CA2426210C (en) 2009-12-22
CN1771929A (zh) 2006-05-17
PL361028A1 (en) 2004-09-20
MXPA03003589A (es) 2005-08-16
CA2426210A1 (en) 2002-05-02
HRP20030322A2 (en) 2005-02-28
NO20031814L (no) 2003-06-19
EP1335717A1 (en) 2003-08-20
AU4201101A (en) 2002-05-06
EP1335717A4 (en) 2004-06-30
AU2001242011B8 (en) 2006-03-02
HUP0301441A2 (hu) 2003-11-28
US6395783B1 (en) 2002-05-28
IL155574A (en) 2010-02-17
NO20031814D0 (no) 2003-04-23

Similar Documents

Publication Publication Date Title
Dodd et al. Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy
EP2224917B1 (en) Composition comprising nicotine and opipramol and use thereof
Meil et al. Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine
Gamberino et al. Neurobiology of tobacco smoking and other addictive disorders
DE69931789T2 (de) Behandlung von nicotinsucht und sucht bedingtem verhalten
de Wit et al. Drug reinstatement of heroin-reinforced responding in the rat
De Witte Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol
US6232326B1 (en) Treatment for schizophrenia and other dopamine system dysfunctions
Kiianmaa et al. Effect of ethanol on extracellular dopamine in the nucleus accumbens of alcohol-preferring AA and alcohol-avoiding ANA rats
JP6676062B2 (ja) 認知低下を処置するための方法
Taepavarapruk et al. Neurochemical correlates of relapse to d-amphetamine self-administration by rats induced by stimulation of the ventral subiculum
US20150051192A1 (en) Blocking of cue-induced drug reinstatement
KR20120101473A (ko) 아라키돈산 유사체 및 이를 사용한 진통제 치료 방법
Collins et al. Progress towards the development of animal models of smoking-related behaviors
Caprioli et al. Environmental modulation of cocaine self-administration in the rat
Santamaría et al. Neurochemical and behavioral effects elicited by bupropion and diethylpropion in rats
Steinmiller et al. Effects of dextromethorphan on dopamine release in the nucleus accumbens: Interactions with morphine
Rosecrans et al. Discriminative stimulus properties of S (−)-nicotine:“a drug for all seasons”
KR20030074610A (ko) Ｐｃｐ 중독 및 ｐｃｐ 중독 관련 행동의 치료방법
Essman Clinical pharmacology of learning and memory
Karami et al. Sulpiride injections into the medial septum reverse the influence of intra-medial septum injection of L-arginine on expression of place conditioning-induced by morphine in rats
Steketee Repeated injection of GBR 12909, but not cocaine or WIN 35,065-2, into the ventral tegmental area induces behavioral sensitization
KR20040020054A (ko) 통증 치료시 중독 예방
Stairs et al. Effects of nornicotine enantiomers on intravenous S (−)-nicotine self-administration and cardiovascular function in rats
Olive et al. Conditioning of addiction

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20030423

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20060117

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20061124

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20070207

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20061124

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I